Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise

Patent metadata

Field	Value
Publication number	US-12433485-B2
Application number	US-202017009463-A
Country	US
Kind code	B2
Filing date	Sep 1, 2020
Priority date	May 18, 2007
Publication date	Oct 7, 2025
Grant date	Oct 7, 2025

Abstract

Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.

First claim

What is claimed is:

1. A glucose sensor configured for implantation in a host, the glucose sensor comprising:
an ex vivo portion and an in vivo portion, wherein the in vivo portion comprises:
a reference electrode disposed at least in part on the in vivo portion of the glucose sensor,
an electrode comprising a plurality of electroactive surfaces each configured to measure a signal indicative of a glucose concentration of the host, wherein the signal comprises a glucose-related component and a non-glucose related component, wherein the plurality of electroactive surfaces comprise a first electroactive surface, a second electroactive surface, and a third electroactive surface spaced along a length of the in vivo portion;
an enzyme configured to react with glucose; and
a membrane covering at least a portion of the electrode and the enzyme, wherein the membrane comprises an outer domain formed from a blend comprising at least 5 wt. % of a hydrophilic component,

wherein the first electroactive surface, the second electroactive surface, and the third electroactive surface share a central axis, wherein the central axis is an axis of sensor insertion.

2. The glucose sensor of claim 1 , wherein the membrane is configured to reduce passage of an interfering species having an oxidation potential that overlaps with an oxidation potential of a measured species indicative of the glucose concentration.

3. The glucose sensor of claim 2 , wherein the measured species is a product of an enzymatic reaction between glucose and the enzyme and is measured by the electrode.

4. The glucose sensor of claim 1 , wherein the membrane comprises a silicone-containing polymer.

5. The glucose sensor of claim 4 , wherein the silicone-containing polymer is a polysiloxane or a polycarbosiloxane.

6. The glucose sensor of claim 1 , wherein the glucose sensor has a planar shape.

7. The glucose sensor of claim 4 wherein the silicone-containing polymer is a copolymer comprising a polysiloxane segment and a polyurethane segment.

8. The glucose sensor of claim 1 , wherein the membrane comprises a fluorocarbon-based material.

9. The glucose sensor of claim 1 , wherein the non-glucose-related component is less than about 10% of the signal over a time period of at least about one day when implanted in the host.

10. The glucose sensor of claim 1 , wherein the glucose sensor has a sensitivity to glucose of from about 5 pA/mg/dL to about 100 pA/mg/dL.

11. The glucose sensor of claim 1 , wherein the non-glucose-related component is less than about 20% of the signal over a time period of at least about one day when implanted in the host.

12. A glucose sensor configured for implantation in a host using at least a retractable needle separate from the glucose sensor, the glucose sensor comprising:
an electrode comprising a plurality of electroactive surfaces each configured to measure a signal indicative of a glucose concentration of the host, wherein the plurality of electroactive surfaces comprise a first electroactive surface, a second electroactive surface, and a third electroactive surface, wherein the plurality of electroactive surfaces are spaced along a length of an in vivo portion of the glucose sensor;
an enzyme configured to react with glucose; and
a membrane covering at least a portion of the electrode, wherein the membrane comprises an outer domain formed from a blend comprising at least about 5 wt. % of a hydrophilic component,
wherein the first electroactive surface, the second electroactive surface, and the third electroactive surface are centrally aligned with an axis of sensor insertion.

13. The glucose sensor of claim 12 , wherein the blend comprises a silicone-containing polymer.

14. The glucose sensor of claim 12 , wherein the membrane comprises a fluorocarbon-based material.

15. The glucose sensor of claim 12 , wherein the hydrophilic component is a copolymer of poly(ethylene oxide) and poly(propylene oxide).

16. The glucose sensor of claim 12 , wherein the blend comprises a polyurethane-based domain that has been surface-treated with a polymer containing hydrophilic moieties.

17. The glucose sensor of claim 12 , wherein the outer domain comprises at least about 15 wt. % of the hydrophilic component.

18. The glucose sensor of claim 12 , wherein the outer domain comprises at least about 25 wt. % of the hydrophilic component.

19. The glucose sensor of claim 12 , wherein the glucose sensor has a sensitivity to glucose of from about 5 pA/mg/dL to about 500 pA/mg/dL.

20. The glucose sensor of claim 12 , wherein the glucose sensor has a sensitivity to glucose of from about 5 pA/mg/dL to about 100 pA/mg/dL.

21. The glucose sensor of claim 1 , wherein each of the plurality of electroactive surfaces is an external surface of the electrode.

22. The glucose sensor of claim 1 , wherein each of the plurality of electroactive surfaces is an outwardly facing surface.

23. The glucose sensor of claim 1 , wherein the membrane comprises a polyether-containing polymer.

24. The glucose sensor of claim 1 ,
wherein the in vivo portion of the glucose sensor comprises a distal end, and
wherein the first electroactive surface, the second electroactive surface, and the third electroactive surface are located closer to the distal end of the in vivo portion of the glucose sensor than the reference electrode.

25. The glucose sensor of claim 12 , wherein the glucose sensor has a planar shape.

26. The glucose sensor of claim 1 , wherein the membrane is configured to decrease diffusion of at least one interferent of reactive oxygen or nitrogen, therethrough.

27. The glucose sensor of claim 1 , wherein the membrane comprises a layer configured to control a diffusion of glucose therethrough.

28. The glucose sensor of claim 27 , wherein the layer comprises polyurethane.

Assignees

• Dexcom Inc

Inventors

• Simpson Peter C
• Boock Robert J
• Brister Mark C
• Rixman Swinney Monica A
• Woo Kum Ming
• Nguyen Lisa
• Brunner Seth R
• Chee Arthur
• Nicholas Melissa A
• Wightlin Matthew D
• Pryor Jack
• Markovic Dubravka

Classifications

• A61B5/14735

  comprising an immobilised reagent · CPC title

• A61B5/1473

  invasive, e.g. introduced into the body by a catheter · CPC title

• A61B5/14532 Primary

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/14546

  for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

• A61B5/14865

  invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title